Status:
COMPLETED
Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin.
Lead Sponsor:
Bayer
Conditions:
Pelvic Inflammatory Disease
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
Comparison of various antibiotics in treatment of uncomplicated pelvic inflammatory disease
Eligibility Criteria
Inclusion
- Diagnosis of PID based on: pelvic discomfort- Direct lower abdominal tenderness;
- Adnexal tenderness on bimanual vaginal examination,
- Temperature \> 38.0°C; - Elevated C-reactive protein value (CRP);
- Signed PIC/IC
Exclusion
- Pregnancy
- Abnormal lab values
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2004
Estimated Enrollment :
749 Patients enrolled
Trial Details
Trial ID
NCT00683865
Start Date
April 1 2003
End Date
October 1 2004
Last Update
October 15 2014
Active Locations (77)
Enter a location and click search to find clinical trials sorted by distance.
1
Hvidovre, Denmark, 2650
2
Odense C, Denmark, DK-5000
3
Roskilde, Denmark, DK-4000
4
Hämeenlinna, Finland, 13530